Back to Search
COREY LANGER, MD
MD
Hematology & Oncology Physician
NPI: 1811918501IndividualAccepts Medicare
Specialties, Licenses & Credentials
Internal Medicine Physician
Internal Medicine
Code: 207R00000X
MD028074E(PA)
Hematology & Oncology PhysicianPrimary
Internal Medicine — Hematology & Oncology
Code: 207RH0003X
MD028074E(PA)
CMS Specialties
PrimaryHEMATOLOGY/ONCOLOGY
Education
BOSTON UNIVERSITY SCHOOL OF MEDICINE
Class of 1981
Research & Publications (20)
Targeted therapy in head and neck cancer: state of the art 2007 and review of clinical applications.
PMID 18442098·Cancer·2008
6-review
Resectable non-small cell lung cancer in the elderly: is there a role for adjuvant treatment?
PMID 18331073·Drugs Aging·2008
6-review
Cooperative group portfolio in locally advanced non-small-cell lung cancer: are we making progress?
PMID 18501094·Clin Lung Cancer·2008
6-review
Phase III trial comparing paclitaxel poliglumex (CT-2103, PPX) in combination with carboplatin versus standard paclitaxel and carboplatin in the treatment of PS 2 patients with chemotherapy-naïve advanced non-small cell lung cancer.
PMID 18520802·J Thorac Oncol·2008
3-trial
Phase II study of low-dose paclitaxel and cisplatin in combination with split-course concomitant twice-daily reirradiation in recurrent squamous cell carcinoma of the head and neck: results of Radiation Therapy Oncology Group Protocol 9911.
PMID 17947728·J Clin Oncol·2007
3-trial
Phase I study of radical thoracic radiation, weekly irinotecan, and cisplatin in locally advanced non-small cell lung carcinoma.
PMID 17410043·J Thorac Oncol·2007
3-trial
Randomized phase II trial of paclitaxel plus carboplatin or gemcitabine plus cisplatin in Eastern Cooperative Oncology Group performance status 2 non-small-cell lung cancer patients: ECOG 1599.
PMID 17264337·J Clin Oncol·2007
3-trial
Effectiveness versus convenience: patient preferences for an erythropoietic agent to treat cancer-related anemia.
PMID 17257469·Curr Med Res Opin·2007
8-other
Osteonecrosis of the jaw, a recently recognized sequela of bisphosphonate therapy: case report.
PMID 18632450·Support Cancer Ther·2006
8-other
Phase I trial of concurrent hyperfractionated split course radiotherapy (HFx RT), cisplatin (cDDP), and paclitaxel in patients with recurrent, previously irradiated, or treatment-naïve locally advanced upper aerodigestive malignancy.
PMID 16537186·Cancer Invest·2006
3-trial
Neglected and underrepresented subpopulations: elderly and performance status 2 patients with advanced-stage non-small-cell lung cancer.
PMID 16764753·Clin Lung Cancer·2006
6-review
The emerging role of vascular endothelial growth factor receptor tyrosine kinase inhibitors.
PMID 16459176·Semin Oncol·2005
6-review
Current management of brain metastases, with a focus on systemic options.
PMID 16135488·J Clin Oncol·2005
6-review
Patterns of care survey (PCS) in lung cancer: how well does current U.S. practice with chemotherapy in the non-metastatic setting follow the literature?
PMID 15777975·Lung Cancer·2005
8-other
Role of zoledronic acid in the setting of bone metastases from non-small-cell lung cancer.
PMID 15845184·Clin Lung Cancer·2005
5-case
Role of chemotherapy in patients with poor performance status and advanced non-small cell lung cancer.
PMID 15599829·Semin Oncol·2004
6-review
CT-2103: a novel macromolecular taxane with potential advantages compared with conventional taxanes.
PMID 15638965·Clin Lung Cancer·2004
6-review
Phase II evaluation of 96-hour paclitaxel infusion in advanced (recurrent or metastatic) squamous cell carcinoma of the head and neck (E3395): a trial of the Eastern Cooperative Oncology Group.
PMID 15641479·Cancer Invest·2004
3-trial
Patients with non-small cell lung cancer and poor performance status: a significant population with limited data.
PMID 15599827·Semin Oncol·2004
8-other
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 3400 CIVIC CENTER BLVD FL 3
PHILADELPHIA, PA 19104 - Phone
- (215) 615-5858
Quick Facts
- NPI
- 1811918501
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Accepted
- Specialties
- 2
- Locations
- 1
- Years in Practice
- 45
- Publications
- 20
Are you this provider?
Claim Your Profile